Impedimed Ltd (OTCPK:IPDQF)
$ 0.0421 0 (0%) Market Cap: 72.33 Mil Enterprise Value: 57.27 Mil PE Ratio: 0 PB Ratio: 4.21 GF Score: 0/100

Q3 2021 ImpediMed Ltd Earnings Call Transcript

Apr 27, 2021 / 11:15PM GMT
Release Date Price: $0.1045
Unidentified Participant

Good morning, everyone, and thank you for joining ImpediMed's Quarterly Results Investor Webcast this morning.

(Operator Instructions) Today's webcast will feature a short presentation from ImpediMed's Managing Director and CEO, Mr. Richard Carreon; and CFO, Tim Cruickshank. This will be followed by a Q&A. (Operator Instructions) Please note we will hold all questions until the conclusion of the presentation.

I would now like to hand over to Richard Carreon, Managing Director and CEO.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 31 March 2021.

Joining us on the call today is Tim Cruickshank, our Chief Financial Officer; and Mike Bassett, our Senior Vice President of Corporate and Strategic Development.

I'll be referencing the 4C and speaking from the financial presentation we lodged this morning Australian time. This

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot